News
Limited-Edition Apparel Capsule Accompanies Classic Nylon Plus and Club C Revenge Models (BOSTON) May 5, 2025 – Today, Reebok ...
President and CEO of Electronic Design & Manufacturing Bree Oldham will address students in Central Virginia Community ...
Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell ...
The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...
VectorY Therapeutics (VectorY), a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced that it will have four feat ...
In a joint developer track session with Imagination Technologies and Andes Technology, Baya chief software architect Dr. Eric ...
8d
Clinical Trials Arena on MSNPacira’s gene therapy shows sustained benefits in trial for knee osteoarthritisPacira BioSciences has announced that its gene therapy candidate, PCRX-201 (enekinragene inzadenovec), has demonstrated ...
bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird" or "the Company"), Carlyle (NASDAQ: CG) ("Carlyle"), SK Capital Partners, LP ("SK Capital") and Beacon Parent Holdings, L.P. ("Parent") announced today ...
Signage in Gladstone will look different in the future, as the city just adopted a new logo and branding package after ...
TG4050: Updated randomized Phase I data to be presented in Rapid Oral Presentation at ASCO 2025 Dr. Simone Steiner appointed Chief Technical Officer (CTO) Business funded until the end of April 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results